Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lipid nanostructures for targeting brain cancer
Hamdi Nsairat, Dima Khater, Fadwa Odeh, et al.
Heliyon (2021) Vol. 7, Iss. 9, pp. e07994-e07994
Open Access | Times Cited: 46

Showing 1-25 of 46 citing articles:

Liposomes: structure, composition, types, and clinical applications
Hamdi Nsairat, Dima Khater, Usamah Sayed, et al.
Heliyon (2022) Vol. 8, Iss. 5, pp. e09394-e09394
Open Access | Times Cited: 646
Recent advances in using liposomes for delivery of nucleic acid-based therapeutics
Hamdi Nsairat, Walhan Alshaer, Fadwa Odeh, et al.
OpenNano (2023) Vol. 11, pp. 100132-100132
Open Access | Times Cited: 59
Unravelling the in vivo dynamics of liposomes: Insights into biodistribution and cellular membrane interactions
Sharanya Paramshetti, Mohit Angolkar, Sirajunisa Talath, et al.
Life Sciences (2024) Vol. 346, pp. 122616-122616
Closed Access | Times Cited: 19
Natural compounds-based nanomedicines for cancer treatment: Future directions and challenges
Tatiana Andreani, Ruoyu Cheng, Khalil Elbadri, et al.
Drug Delivery and Translational Research (2024) Vol. 14, Iss. 10, pp. 2845-2916
Open Access | Times Cited: 16
Advancing neurological disorders therapies: Organic nanoparticles as a key to blood-brain barrier penetration
Zahra Razavi, Seyed Sina Alizadeh, F. S. Razavi, et al.
International Journal of Pharmaceutics (2025) Vol. 670, pp. 125186-125186
Open Access | Times Cited: 5
Lipid-Based Nanocarriers for Neurological Disorders: A Review of the State-of-the-Art and Therapeutic Success to Date
Bwalya A. Witika, Madan Poka, Patrick H. Demana, et al.
Pharmaceutics (2022) Vol. 14, Iss. 4, pp. 836-836
Open Access | Times Cited: 41
Nanostructured lipid carrier system: A compendium of their formulation development approaches, optimization strategies by quality by design, and recent applications in drug delivery
Shamama Javed, Bharti Mangla, Yosif Almoshari, et al.
Nanotechnology Reviews (2022) Vol. 11, Iss. 1, pp. 1744-1777
Open Access | Times Cited: 41
Micro‐Nanocarriers Based Drug Delivery Technology for Blood‐Brain Barrier Crossing and Brain Tumor Targeting Therapy
Luyao Wang, Youyuan Shi, Jingzhen Jiang, et al.
Small (2022) Vol. 18, Iss. 45
Closed Access | Times Cited: 41
Liposome bilayer stability: emphasis on cholesterol and its alternatives
Hamdi Nsairat, Abed Alqader Ibrahim, Areej M. Jaber, et al.
Journal of Liposome Research (2023) Vol. 34, Iss. 1, pp. 178-202
Closed Access | Times Cited: 33
Role of siRNA-based nanocarriers for the treatment of neurodegenerative diseases
Neeraj Mishra, Sumel Ashique, Ashish Garg, et al.
Drug Discovery Today (2022) Vol. 27, Iss. 5, pp. 1431-1440
Closed Access | Times Cited: 30
Hyaluronic Acid – Coated Niosomes for Curcumin Targeted Delivery into Breast Cancer Cells
Zahraa M. Al Zubaidi, Hamdi Nsairat, Naeem Shalan, et al.
ChemistrySelect (2024) Vol. 9, Iss. 3
Closed Access | Times Cited: 5
Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation
Andreea Crintea, A Duţu, Alina Simona Șovrea, et al.
Nanomaterials (2022) Vol. 12, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 26
Dysregulated lipid metabolism in TMZ-resistant glioblastoma: pathways, proteins, metabolites and therapeutic opportunities
Tzu‐Jen Kao, Chien-Liang Lin, Wen‐Bin Yang, et al.
Lipids in Health and Disease (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Harnessing the potential of nanoengineered siRNAs carriers for target responsive glioma therapy: Recent progress and future opportunities
Kailash Ahirwar, Ankit Kumar, Nidhi Srivastava, et al.
International Journal of Biological Macromolecules (2024) Vol. 266, pp. 131048-131048
Closed Access | Times Cited: 4
In vivo evaluation of mebendazole and Ran GTPase inhibition in breast cancer model system
Balqis Abu-Hdaib, Hamdi Nsairat, Mohamed El‐Tanani, et al.
Nanomedicine (2024) Vol. 19, Iss. 12, pp. 1087-1101
Closed Access | Times Cited: 4
Oligonucleotides as a Novel Therapeutic Approach: An Innovative Area for Drug Delivery in Neurological Disorders
Yasir Q. Аlmajidi, Rana Kadum Muslim, Yaseen T. khalf
Al Mustansiriyah Journal of Pharmaceutical Sciences (2025) Vol. 25, Iss. 1, pp. 143-169
Open Access
In Vitro Potentiation of Doxorubicin Cytotoxicity Utilizing Clarithromycin Loaded-PEGylated Liposomes
Islam Alfreahat, Hamdi Nsairat, Ibrahim Al‐Deeb, et al.
Technology in Cancer Research & Treatment (2025) Vol. 24
Open Access
Lipid-Based Nanoparticles for Neurological Drug Discovery
Chandran Sathya, S. Natarajan, Bhagavathi Sundaram Sivamaruthi
Nanotechnology in the life sciences (2025), pp. 283-301
Closed Access
Nanomedicine: Pioneering Advances in Neural Disease, Stroke and Spinal Cord Injury Treatment
Borish Loushambam, Sangeeta Yanglem, Venkatraman Krishnaswami, et al.
Neuroglia (2025) Vol. 6, Iss. 1, pp. 9-9
Open Access
Pulmonary drug delivery of lipid-based formulations via nebulizers
Anas Islam, Ambareen Fatima Ahmed, Widhilika Singh, et al.
Elsevier eBooks (2025), pp. 449-490
Closed Access
Preparation, Characterization, and Anticancer Activity of PEGylated Nano Liposomal Loaded with Rutin against Human Carcinoma Cells (HT‐29)
Noorin Manhal Al‐Ekaid, Ali Al‐Samydai, Ibrahim Al‐Deeb, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 11
Closed Access | Times Cited: 12
State-of-the-Art of Synthesized Exosomes and NPs-Based Biomimetic Nanoparticles for Wound Rehabilitation: A Review
Eliasu Issaka
Deleted Journal (2023) Vol. 2, Iss. 1, pp. 241-274
Open Access | Times Cited: 8
Natural Food Components as Biocompatible Carriers: A Novel Approach to Glioblastoma Drug Delivery
Arunraj Tharamelveliyil Rajendran, Anoop Narayanan Vadakkepushpakath
Foods (2024) Vol. 13, Iss. 17, pp. 2812-2812
Open Access | Times Cited: 2
Myrtenol‐Loaded Fatty Acid Nanocarriers Protect Rat Brains Against Ischemia–Reperfusion Injury: Antioxidant and Anti‐Inflammatory Effects
S Karimi Afshar, Farzaneh Rostamzadeh, Mohammad Reza Bigdeli, et al.
Chemical Biology & Drug Design (2024) Vol. 104, Iss. 3
Closed Access | Times Cited: 2
Formulation, development, and in vitro evaluation of a nanoliposomal delivery system for mebendazole and gefitinib
Maram Kutkut, Ashok K. Shakya, Hamdi Nsairat, et al.
Journal of Applied Pharmaceutical Science (2023)
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top